Tag: bicuspid aortic valve
STS 2022: Large-scale analysis points toward positive outcomes in bicuspid aortic stenosis patients receiving surgery
Insights from what was described as the “largest and most comprehensive” analysis of isolated su...
PCR e-Course 2020: Bicuspid TAVI is feasible, safe and efficient
The feasibility, safety, and efficiency of transcatheter aortic valve implantation (TAVI) using ...
Evolut gets CE mark in low-risk patients and new labelling for bicuspid use
Medtronic has been awarded CE mark for the use of the Evolut transcatheter aortic valve implanta...
Virtual ACC: High success rate for TAVI in bicuspid aortic stenosis patients
Transcatheter aortic valve implantation (TAVI) procedures had a high rate of success and low ris...
US FDA approve study of CoreValve Evolut in low-risk patients with bicuspid valves
The US FDA has approved an investigational device exemption (IDE) to initiate a single-arm study...
“Tricuspidisation” could be a potential approach to performing TAVI in certain patients with bicuspid valves
At present, a bicuspid aortic valve is seen as a relative contradiction for transcatheter aortic...
US FDA clears Biostable’s HAART 200 bicuspid aortic valve repair annuloplasty device
BioStable Science & Engineering has received US Food and Drug Administration (FDA) market cl...
Bicuspid aortic stenosis: TAVI’s next challenge
Most of the initial registries, and the large randomised trials, for transcatheter aortic valve ...
